JPH029561B2 - - Google Patents
Info
- Publication number
- JPH029561B2 JPH029561B2 JP56167694A JP16769481A JPH029561B2 JP H029561 B2 JPH029561 B2 JP H029561B2 JP 56167694 A JP56167694 A JP 56167694A JP 16769481 A JP16769481 A JP 16769481A JP H029561 B2 JPH029561 B2 JP H029561B2
- Authority
- JP
- Japan
- Prior art keywords
- collagen
- weight
- cosmetic
- cosmetic lotion
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108010035532 Collagen Proteins 0.000 claims description 64
- 102000008186 Collagen Human genes 0.000 claims description 64
- 229920001436 collagen Polymers 0.000 claims description 64
- 239000008341 cosmetic lotion Substances 0.000 claims description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- 239000007900 aqueous suspension Substances 0.000 claims description 10
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 8
- 239000003381 stabilizer Substances 0.000 claims description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- 230000007928 solubilization Effects 0.000 claims description 7
- 238000005063 solubilization Methods 0.000 claims description 7
- 239000011780 sodium chloride Substances 0.000 claims description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 5
- 239000000600 sorbitol Substances 0.000 claims description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
- 229930195725 Mannitol Natural products 0.000 claims description 4
- 239000000594 mannitol Substances 0.000 claims description 4
- 235000010355 mannitol Nutrition 0.000 claims description 4
- 239000001103 potassium chloride Substances 0.000 claims description 4
- 235000011164 potassium chloride Nutrition 0.000 claims description 4
- 239000001509 sodium citrate Substances 0.000 claims description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
- 239000006097 ultraviolet radiation absorber Substances 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 16
- 239000006210 lotion Substances 0.000 description 12
- 235000019441 ethanol Nutrition 0.000 description 11
- 150000003839 salts Chemical class 0.000 description 11
- 238000004220 aggregation Methods 0.000 description 10
- 230000002776 aggregation Effects 0.000 description 10
- 239000003755 preservative agent Substances 0.000 description 8
- 238000004925 denaturation Methods 0.000 description 7
- 230000036425 denaturation Effects 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000002335 preservative effect Effects 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 150000008163 sugars Chemical class 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 210000002808 connective tissue Anatomy 0.000 description 4
- 239000008406 cosmetic ingredient Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- -1 Polyoxyethylene Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000006096 absorbing agent Substances 0.000 description 3
- 239000012190 activator Substances 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 230000003381 solubilizing effect Effects 0.000 description 3
- 230000006641 stabilisation Effects 0.000 description 3
- 238000011105 stabilization Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001447 alkali salts Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 108010045569 atelocollagen Proteins 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 2
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- HXDRSFFFXJISME-UHFFFAOYSA-N butanedioic acid;2,3-dihydroxybutanedioic acid Chemical compound OC(=O)CCC(O)=O.OC(=O)C(O)C(O)C(O)=O HXDRSFFFXJISME-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000008278 cosmetic cream Substances 0.000 description 1
- 239000008271 cosmetic emulsion Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000003505 heat denaturation Methods 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 150000003287 riboflavins Chemical class 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000003009 skin protective agent Substances 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Description
本発明は新規なコラーゲン含有化粧用ローシヨ
ンに関する。更に詳しくは長期間保存後も可溶性
天然コラーゲンが変性、凝集、沈澱を起こさずし
かもそれを適用しても皮膚刺激性の低いコラーゲ
ン含有化粧用ローシヨンに関するものである。可
溶性天然コラーゲンは幼若動物又は動物胎児の皮
膚の結合組織より直接抽出して得られ、分子間お
よび分子内架橋結合を有しない未変化の天然コラ
ーゲンである。従来皮膚の生理的老化過程は真皮
の結合組織において未変化の可溶性コラーゲンが
分子間および分子内架橋結合の生成に伴い不溶性
コラーゲンに変化し、不溶性コラーゲンの含量が
高くなり、その結果皮膚の弾性が低下し湿潤性が
失われ、しわが増加すると言われている。この可
溶性天然コラーゲンについては皮膚を透過して結
合組織の可溶性コラーゲンの消失を阻止し又は可
溶性コラーゲンを補給してその弾性を増加させし
わを予防するという考え方の下に皮膚保護剤(特
公昭52―8384)として用いられてきた。
近年可溶性コラーゲンに関する研究が進み、そ
の構造、性状が明らかになるにつれ上記の考え方
には疑問がもたれむしろ可溶性天然コラーゲンに
ついてその優れた保水効果が注目されはじめてお
り、この保水効果を利用した化粧用クリーム、化
粧用乳液および化粧用ローシヨンが一部において
研究されている現状にある。しかしながら化粧用
ローシヨンの如く水系化粧料においては、可溶性
天然コラーゲンを単にそのまま各種の化粧料に混
合しただけでは溶解性の減少、加水分解、経日凝
集沈澱等の問題を生じ、著しく不安定である。
一方、天然のコラーゲンが熱変性によりゼラチ
ン化したものや、酸、アルカリ処理により分解し
た低分子ペプタイドは水に溶けやすく溶解性の減
少、経日凝集沈澱は起らないため、これらの水溶
液は比較的安定である。さらに蛋白分解酵素によ
り天然コラーゲン分子の末端部分に存在するテロ
ペプタイドを選択的に消化除去したアテロコラー
ゲンも同様に水に溶けやすく、安定なローシヨン
類を得ることは容易である(特開昭54―110336)。
可溶性天然コラーゲンは、これら低分子ポリペ
プタイドや酵素処理アテロコラーゲンとは異な
り、ローシヨンの如く水系化粧料においては溶解
性が十分ではなく、コラーゲン繊維分子が規則的
に配列を起こし経時的に、凝集沈澱を生じやす
い。
例えば可溶性天然コラーゲンの等電点はPH値
5.8であり弱酸性領域では容易に凝集沈澱を生じ、
またアルコールを用いた場合はコラーゲンが変性
をうけ凝集、沈澱を促進し、カチオン活性剤また
はアニオン活性剤などの界面活性剤はコラーゲン
と複合体を形成したりコラーゲン分子に変性を起
こし、濁りを生じたり経日凝集をおこし実用に供
し難い。
従つて商品価値の高いコラーゲン含有化粧用ロ
ーシヨンの製剤化は実質的に不可能であつたとい
える。
本発明は上記の如き化粧用ローシヨンにおける
問題点を解決すると共に従来に無い優れた化粧用
ローシヨンを得んものと鋭意研究した結果ついに
本発明を完成するに到つた。
本発明は安定なコラーゲン含有化粧用ローシヨ
ンにおいて、可溶化安定剤として塩化ナトリウ
ム、塩化カリウムまたはクエン酸ナトリウムのう
ちいづれか1つ又はそれ以上,0.5―2重量%,
およびブドウ糖,ソルビトールまたはマンニトー
ルのうちいづれか1つ又はそれ以上3―10重量%
を含有した水75―95重量%中に,分子量約30万の
可溶性天然(未処理)コラーゲン0.3―3重量%
の水性懸濁物0.1―5重量%含有せしめることを
特徴とする安定なコラーゲン含有化粧用ローシヨ
ンに関するもので、皮膚に適用することにより皮
膚角質層に適度な潤いを与え皮膚をなめらか(平
滑)にし、はりを与えることを目的とする。
本発明の目的の一つは前述の如き問題を解決し
可溶性天然コラーゲンの化粧料系での安定化を図
ることにある。本発明の化粧用ローシヨンとは通
常の整肌栄養化粧水の他、収れん化粧水、拭き取
り化粧水、シエープローシヨン、ボデイローシヨ
ン、液状パツク等をいう。本発明に適用されるコ
ラーゲンは可溶性天然(未処理)コラーゲンで分
子量約30万のものである。通常可溶性天然コラー
ゲンは幼若動物または動物胎児の皮膚、骨、腱な
どの結合組織より直接抽出して得られる分子間お
よび分子内架橋結合を有せず又コラーゲンのポリ
ペプチド鎖が酸、アルカリまたは酵素で分解をう
けていないものである。
本発明に適用される可溶性天然(未処理)コラ
ーゲンの性状は、薄い乳白色不透明の液で、弱酸
(PH3.0〜5.0)で抽出した水性懸濁物である。本
水性懸濁物は0.3〜3重量%の可溶性天然コラー
ゲンを含有するものである。
本発明に適用される可溶化安定剤は、塩類とし
ては塩化ナトリウム、塩化カリウム、クエン酸ナ
トリウム等の中性塩、糖類としてブドウ糖、ソル
ビトール、マンニトールなどの単糖類がコラーゲ
ンの可溶化安定剤として最も好ましい。これら中
性塩または単糖類はそれぞれ単独または2種以上
を混合して用いてもよい。コラーゲンの可溶化安
定化には塩類および糖類の両者を組み合せて用い
ることが必須で、濃度は塩類0.5〜2重量%、糖
類3〜10重量%の範囲が好ましい。塩類2%およ
び糖類10%以上では皮膚に対する刺激性が高くな
り、ベとつきが現れ使用感が悪くなり、また塩類
0.5%および糖類3%以下ではコラーゲンの可溶
化安定化が不十分であるため全重量中塩類0.5〜
2重量%及び糖類3〜10重量%とすることが好ま
しい。
天然コラーゲンの可溶化安定化に用いるこれら
塩類または糖類は上記の濃度においては、本発明
の化粧用ローシヨンを皮膚に適用したとき皮膚に
対し好ましい保湿作用も期待できるものである。
本発明においては上記コラーゲンと塩類および
糖類からなる可溶化安定剤に水を加えた3つの成
分を必須成分とし、可溶化安定剤として塩類と糖
類を上記の重量%で組み合わせて用いることが必
須条件で、かつPH領域を4〜10に保持することが
必要である。PH4以下およびPH10以上では皮膚に
適用する使用感および刺激性の点で好ましくな
く、PH10以上ではコラーゲンがゼラチン化を起こ
したり加水分解による低分子化を起こすため可溶
性天然コラーゲンの効果を失うためで最適にはPH
5〜9の範囲がよい。PH調整剤としてはリン酸系
炭酸系の無機酸ならびにそのアルカリ塩、クエン
酸、コハク酸酒石酸、リンゴ酸等の有機酸ならび
にそのアルカリ塩を全重量中1%程度以下で用い
ることが効果的である。本化粧用ローシヨンはそ
の他の主な化粧料成分として保湿剤、アルコール
類、界面活性剤、紫外線吸収剤、種々の薬効成
分、キレート剤等を用いることができる。
保湿剤は尿素、アミノ酸、ペプチド、乳酸塩、
PCA塩、グリセリンなどを用いることが可能で
ある。アルコール類はエチルアルコール、イソプ
ロピルアルコール等でコラーゲンの経日による変
性、凝集、沈澱および皮膚に対する刺激性を考慮
し10重量%程度までが使用可能な範囲である。界
面活性剤としてはカチオン活性剤、アニオン活性
剤はコラーゲンと複合体を形成したりコラーゲン
分子に変性をおこし、濁りを生じたり経日凝集を
おこし系での安定化が不良であるため使用を避け
るべきである。エーテル系ノニオン活性剤、エス
テル系ノニオン活性剤は使用することが可能であ
るが、とくにエーテル系ノニオン活性剤が良好で
あり、3重量%以下の使用が好ましい。紫外線吸
収剤としてはウロカニン酸系、ベンゾフエノン系
または安息香酸系を0.01〜2.00重量%の範囲で用
いることが好ましい。薬効成分としてはグリチル
リチン酸およびその誘導体、グリチルレチン酸お
よびその誘導体アラントインなどの抗炎症剤、ビ
タミンE、ビタミンB2誘導体などのビタミン類、
γ―オリザノールの如き血行促進剤等を用いるこ
とも可能である。
また本発明は通常の化粧用ローシヨンの如く香
料、防腐剤、色素、増粘剤等の化粧用原料を必要
に応じて用いることは言うまでもない。
次に本発明の製造法について述べると予め油溶
性化粧料成分(薬効成分、紫外線吸収剤、界面活
性剤、香料等)を溶解したアルコールに、水溶性
化粧料成分(可溶化安定剤、PH調整剤、薬効成
分、防腐剤、紫外線吸収剤等)を溶解(必要なら
ば加熱)した水を徐々に加え完全に混和溶解し、
次いで40℃以下で可溶性天然(未処理)コラーゲ
ンを加えて化粧用ローシヨンを得る方法が最適で
ある。可溶性天然コラーゲンは熱による変性を防
ぐため40℃以下の温度で加えることが必要であ
り、またコラーゲンと直接接触することにより変
性凝集を起こさせるような化粧料成分とくにアル
コールとの接触を出来るだけ避けるため上述の如
く、コラーゲンを最終段階で加えることが安定な
化粧用ローシヨンを得るために重要である。
上記の如くして得られた本発明化粧用ローシヨ
ンは、分子量約30万の可溶性天然(未処理)コラ
ーゲンの系への長期安定化を図り、可溶性天然コ
ラーゲンの有する優れた保水効果を効果的に発揮
させ得るもので従来の保湿剤のみを用いた化粧用
ローシヨンでは得られないしつとり感(潤い)を
皮膚角質層に与え皮膚とよくなじみ皮膚をなめら
か(平滑)にし、はりを与え得るものである。
次に本発明化粧用ローシヨンの実施例を示す。
配合割合は重量パーセントである。
実施例 1
化粧水
可溶性天然コラーゲン0.3重量%含有
水性懸濁物 0.5
ブドウ糖 5.0
塩化ナトリウム 0.8
炭酸ナトリウム 0.02
防腐剤 0.1
香料(水溶性) 微量
水 93.58
実施例 2
栄養化粧水
可溶性天然コラーゲン3重量%含有
水性懸濁物 2.0
ブドウ糖 3.0
ソルビトール 2.0
塩化ナトリウム 0.8
酢酸de―α―トコフエロール 0.1
エチルアルコール 7.0
1.3―ブチレングリコール 2.0
炭酸ナトリウム 0.2
防腐剤 0.05
香 料 微量
水 82.85
実施例 3
アストリンゼントローシヨン
可溶性天然コラーゲン0.3重量%含有
水性懸濁物 0.1
ブドウ糖 3.0
尿 素 2.0
塩化カリウム 0.5
エチルアルコール 10.0
グリセリン 1.0
クエン酸 0.01
リン酸水素ナトリウム 0.1
ウロカニン酸 0.05
防腐剤 0.05
香 料 微量
水 83.19
実施例 4
整肌化粧水
可溶性天然コラーゲン2重量%含有
水性懸濁物 1.0
ソルビトール 6.0
尿 素 2.0
塩化ナシリウム 0.5
グリチルリチン酸ジカリウム 0.1
エチルアルコール 5.0
ポリオキシエチレン硬化ヒマシ油 0.3
コハク酸 0.01
コハク酸ナトリウム 0.15
p―アミノ酸安息香酸 1.0
防腐剤 0.1
香 料 微量
水 83.84
実施例 5
アフターシエーブローシヨン
可溶性天然コラーゲン0.3重量%含有
水性懸濁物 0.5
クエン酸ナトリウム 0.5
マンニトール 5.0
イソプロピルアルコール 10.0
ポリオキシエチレン硬化ヒマシ油 0.4
プロピレングリコール 3.0
酒石酸 0.1
メントール 0.01
防腐剤 0.05
香 料 微量
水 80.44
実施例 6
液状パツク
可溶性天然コラーゲン3.0重量%含有
水性懸濁物 5.0
ブドウ糖 6.0
ポリエチレングリコール 3.0
塩化ナトリウム 1.0
グリチルレン酸ステアリル 0.05
ポリオキシエチレンオレイルエーテル 0.3
ポリビニールアルコール 5.0
エチルアルコール 5.0
グリセリン 1.0
防腐剤 0.1
香 料 微量
水 74.55
次に本発明による化粧用ローシヨンの経時変化
について述べる。
表の説明
表は本発明による化粧用ローシヨンの経時変化
を本発明で用いている可溶化安定剤を使用しない
同一処方の化粧用ローシヨン(本発明化粧用ロー
シヨンから可溶化安定剤のみを除いたもの)の経
時変化と比較したものである。表1、表2、表
3、表4、表5および表6はそれぞれ実施例1,
2,3,4,5および6の化粧用ローシヨンの外
観性状の経時変化を示す。
表中、―〜の記号は化粧用ローシヨンの外観性
状の変化をコラーゲンの変性の程度により表わし
た。
− 変化なし
± コラーゲンわずかに凝集
+ コラーゲン凝集
コラーゲン凝集沈澱。
The present invention relates to a novel collagen-containing cosmetic lotion. More specifically, the present invention relates to a collagen-containing cosmetic lotion whose soluble natural collagen does not undergo denaturation, aggregation, or precipitation even after long-term storage, and which causes low skin irritation when applied. Soluble natural collagen is obtained by directly extracting the connective tissue of the skin of young animals or animal fetuses, and is unaltered natural collagen having no intermolecular or intramolecular crosslinks. Conventionally, in the physiological aging process of the skin, unchanged soluble collagen in the connective tissue of the dermis changes to insoluble collagen with the generation of intermolecular and intramolecular cross-links, and the content of insoluble collagen increases, resulting in a decrease in skin elasticity. It is said that there is a decrease in wettability and an increase in wrinkles. This soluble natural collagen is used as a skin protective agent (Special Publication No. 1983-1983) based on the idea that it penetrates the skin and prevents the loss of soluble collagen in connective tissues, or replenishes soluble collagen to increase its elasticity and prevent wrinkles. 8384). In recent years, research on soluble collagen has progressed, and as its structure and properties have become clearer, the above concept has been questioned.In fact, soluble natural collagen has begun to attract attention for its excellent water-retaining effect, and cosmetic creams that utilize this water-retaining effect have been developed. Currently, some cosmetic emulsions and lotions are being studied. However, in water-based cosmetics such as cosmetic lotions, if soluble natural collagen is simply mixed into various cosmetics, problems such as decreased solubility, hydrolysis, and aggregation and precipitation over time will occur, making it extremely unstable. . On the other hand, natural collagen gelatinized by heat denaturation and low-molecular peptides decomposed by acid or alkali treatment are easily soluble in water and do not decrease in solubility or aggregate and precipitate over time, so these aqueous solutions are difficult to compare. It is stable. Furthermore, atelocollagen, which is obtained by selectively digesting and removing telopeptides present at the end portions of natural collagen molecules using proteolytic enzymes, is similarly easily soluble in water, making it easy to obtain stable lotions (Japanese Patent Application Laid-open No. 110336-1982). ). Unlike these low-molecular-weight polypeptides and enzyme-treated atelocollagen, soluble natural collagen does not have sufficient solubility in water-based cosmetics such as lotions, and collagen fiber molecules are arranged regularly and aggregate and precipitate over time. Easy to occur. For example, the isoelectric point of soluble natural collagen is the PH value
5.8, easily coagulates and precipitates in weakly acidic areas,
In addition, when alcohol is used, collagen is denatured and promotes aggregation and precipitation, while surfactants such as cationic or anionic surfactants form complexes with collagen or cause denaturation of collagen molecules, resulting in turbidity. It is difficult to put it to practical use because it causes aggregation over time. Therefore, it can be said that it has been virtually impossible to formulate a collagen-containing cosmetic lotion with high commercial value. The present invention has been made to solve the above-mentioned problems in cosmetic lotions, and has finally been completed as a result of intensive research aimed at creating a cosmetic lotion that is superior to the conventional cosmetic lotions. The present invention provides a stable collagen-containing cosmetic lotion comprising 0.5-2% by weight of any one or more of sodium chloride, potassium chloride or sodium citrate as a solubilization stabilizer;
and 3-10% by weight of one or more of glucose, sorbitol or mannitol
0.3-3% by weight of soluble natural (untreated) collagen with a molecular weight of approximately 300,000 in 75-95% by weight of water containing
This is a stable collagen-containing cosmetic lotion characterized by containing 0.1 to 5% by weight of an aqueous suspension of collagen, and when applied to the skin, it provides appropriate moisture to the stratum corneum of the skin and makes the skin smooth. , the purpose of which is to give strength. One of the objects of the present invention is to solve the above-mentioned problems and to stabilize soluble natural collagen in cosmetic systems. The cosmetic lotion of the present invention refers to ordinary skin conditioning and nourishing lotions, as well as astringent lotions, wiping lotions, shape lotions, body lotions, liquid packs, and the like. The collagen applied to the present invention is soluble natural (unprocessed) collagen with a molecular weight of about 300,000. Normally, soluble natural collagen is obtained by directly extracting connective tissues such as the skin, bones, and tendons of young animals or animal fetuses, and has no intermolecular or intramolecular crosslinks. It is not broken down by enzymes. The nature of the soluble natural (unprocessed) collagen applied to the present invention is a thin milky opaque liquid, which is an aqueous suspension extracted with a weak acid (PH3.0-5.0). The aqueous suspension contains 0.3-3% by weight of soluble natural collagen. The solubilizing stabilizers applied to the present invention include neutral salts such as sodium chloride, potassium chloride, and sodium citrate as salts, and monosaccharides such as glucose, sorbitol, and mannitol as sugars. preferable. These neutral salts or monosaccharides may be used alone or in combination of two or more. For solubilization and stabilization of collagen, it is essential to use both salts and sugars in combination, and the preferred concentration is 0.5 to 2% by weight of salts and 3 to 10% by weight of sugars. Salts of 2% or more and sugars of 10% or more are highly irritating to the skin, become sticky and feel uncomfortable to use;
If 0.5% or less and sugars are less than 3%, the solubilization and stabilization of collagen is insufficient, so salts of 0.5 to 0.5% of the total weight
2% by weight and 3 to 10% by weight of sugars. At the above concentrations, these salts or saccharides used to solubilize and stabilize natural collagen can be expected to have a favorable moisturizing effect on the skin when the cosmetic lotion of the present invention is applied to the skin. In the present invention, three essential components are the above-mentioned collagen, a solubilization stabilizer consisting of salts, and saccharides, plus water, and it is an essential condition that salts and saccharides are used in combination at the above-mentioned weight percentage as the solubilization stabilizer. And it is necessary to maintain the PH range between 4 and 10. A pH of 4 or below and a pH of 10 or above is unfavorable in terms of the feeling of use and irritation when applied to the skin, while a pH of 10 or above is optimal because collagen gelatinizes or becomes lower in molecular weight due to hydrolysis, losing the effectiveness of soluble natural collagen. is PH
A range of 5 to 9 is preferable. As a pH adjuster, it is effective to use phosphoric acid-based carbonic acid-based inorganic acids and their alkali salts, and organic acids such as citric acid, succinate-tartaric acid, and malic acid, and their alkali salts in an amount of about 1% or less based on the total weight. be. This cosmetic lotion may contain other main cosmetic ingredients such as humectants, alcohols, surfactants, ultraviolet absorbers, various medicinal ingredients, and chelating agents. Moisturizers include urea, amino acids, peptides, lactate,
It is possible to use PCA salts, glycerin, etc. Alcohols such as ethyl alcohol and isopropyl alcohol can be used in amounts up to about 10% by weight, taking into account denaturation, aggregation, and precipitation of collagen over time, and irritation to the skin. Avoid using cationic surfactants and anionic surfactants because they form complexes with collagen or cause denaturation of collagen molecules, causing turbidity and aggregation over time, resulting in poor stability in the system. Should. Ether type nonionic activators and ester type nonionic activators can be used, but ether type nonionic activators are particularly good, and their use is preferably 3% by weight or less. As the ultraviolet absorber, it is preferable to use urocanic acid type, benzophenone type or benzoic acid type in the range of 0.01 to 2.00% by weight. Medicinal ingredients include anti-inflammatory agents such as glycyrrhetinic acid and its derivatives, glycyrrhetinic acid and its derivative allantoin, vitamins such as vitamin E and vitamin B2 derivatives,
It is also possible to use blood circulation enhancers such as γ-oryzanol. It goes without saying that in the present invention, cosmetic raw materials such as fragrances, preservatives, pigments, thickeners, etc., may be used as necessary in ordinary cosmetic lotions. Next, the manufacturing method of the present invention will be described. Oil-soluble cosmetic ingredients (medicinal ingredients, ultraviolet absorbers, surfactants, fragrances, etc.) are dissolved in alcohol in advance, and water-soluble cosmetic ingredients (solubilization stabilizers, PH adjustment agents, etc.) are dissolved in alcohol. gradually add (heat if necessary) water in which the ingredients (medicinal ingredients, preservatives, ultraviolet absorbers, etc.) have been dissolved (heated if necessary), and mix and dissolve completely.
The optimal method is to then add soluble natural (unprocessed) collagen at a temperature below 40°C to obtain a cosmetic lotion. Soluble natural collagen needs to be added at a temperature below 40℃ to prevent denaturation due to heat, and contact with cosmetic ingredients, especially alcohol, that can cause denaturation and aggregation by direct contact with collagen should be avoided as much as possible. Therefore, as mentioned above, it is important to add collagen at the final stage to obtain a stable cosmetic lotion. The cosmetic lotion of the present invention obtained as described above achieves long-term stabilization of the soluble natural (untreated) collagen system with a molecular weight of approximately 300,000, and effectively utilizes the excellent water-retaining effect of soluble natural collagen. It gives the stratum corneum a moisturizing feeling (moisture) that cannot be obtained with conventional cosmetic lotions using only moisturizers, blends well with the skin, smoothes the skin, and gives firmness. be. Next, examples of the cosmetic lotion of the present invention will be shown. The blending ratio is expressed in weight percent. Example 1 Aqueous suspension containing 0.3% by weight of soluble natural collagen in lotion 0.5 Glucose 5.0 Sodium chloride 0.8 Sodium carbonate 0.02 Preservative 0.1 Fragrance (water soluble) Trace amount of water 93.58 Example 2 Aqueous suspension containing 3% by weight of soluble natural collagen in nutritional lotion Suspension 2.0 Glucose 3.0 Sorbitol 2.0 Sodium chloride 0.8 De-α-tocopherol acetate 0.1 Ethyl alcohol 7.0 1.3-butylene glycol 2.0 Sodium carbonate 0.2 Preservative 0.05 Flavor Trace water 82.85 Example 3 Astringent lotion Contains 0.3% by weight of soluble natural collagen Aqueous suspension 0.1 Glucose 3.0 Urea 2.0 Potassium chloride 0.5 Ethyl alcohol 10.0 Glycerin 1.0 Citric acid 0.01 Sodium hydrogen phosphate 0.1 Urocanic acid 0.05 Preservative 0.05 Fragrance Trace water 83.19 Example 4 Skin conditioning lotion Soluble natural collagen 2% by weight Aqueous suspension containing 1.0 Sorbitol 6.0 Urea 2.0 Nasylium chloride 0.5 Dipotassium glycyrrhizinate 0.1 Ethyl alcohol 5.0 Polyoxyethylene hydrogenated castor oil 0.3 Succinic acid 0.01 Sodium succinate 0.15 p-amino acid benzoic acid 1.0 Preservative 0.1 Flavor Trace water 83.84 Implemented Example 5 Aftershave lotion Aqueous suspension containing 0.3% by weight of soluble natural collagen 0.5 Sodium citrate 0.5 Mannitol 5.0 Isopropyl alcohol 10.0 Polyoxyethylene hydrogenated castor oil 0.4 Propylene glycol 3.0 Tartaric acid 0.1 Menthol 0.01 Preservative 0.05 Fragrance Trace water 80.44 Example 6 Liquid pack Aqueous suspension containing 3.0% by weight of soluble natural collagen 5.0 Glucose 6.0 Polyethylene glycol 3.0 Sodium chloride 1.0 Stearyl glycyrrhenate 0.05 Polyoxyethylene oleyl ether 0.3 Polyvinyl alcohol 5.0 Ethyl alcohol 5.0 Glycerin 1.0 Preservative 0.1 Flavor Trace amount Water 74.55 Next, the aging of the cosmetic lotion according to the present invention will be described. Explanation of the table The table shows the change over time of the cosmetic lotion according to the present invention, and the cosmetic lotion of the same formulation without the solubilizing stabilizer used in the present invention (the cosmetic lotion of the present invention except that only the solubilizing stabilizer was removed). ) compared with the change over time. Table 1, Table 2, Table 3, Table 4, Table 5 and Table 6 represent Example 1,
2 shows changes over time in the appearance and properties of cosmetic lotions Nos. 2, 3, 4, 5 and 6. In the table, the symbols - to - represent changes in the appearance and properties of the cosmetic lotion depending on the degree of collagen denaturation. − No change ± Slight collagen aggregation + Collagen aggregation Collagen aggregation precipitate.
【表】【table】
【表】【table】
【表】【table】
【表】【table】
【表】
室温 ±
± +
45℃ ±
± +
[Table] Room temperature ±
±+
45℃±
±+
【表】【table】
Claims (1)
いて、可溶化安定剤として塩化ナトリウム、塩化
カリウムまたはクエン酸ナトリウムのうちいづれ
か1つ又はそれ以上,0.5―2重量%,およびブ
ドウ糖,ソルビトールまたはマンニトールのうち
いづれか1つ又はそれ以上3―10重量%を含有し
た水75―95重量%中に,分子量約30万の可溶性天
然(未処理)コラーゲン0.3―3重量%の水性懸
濁物0.1―5重量%含有せしめることを特徴とす
る安定なコラーゲン含有化粧用ローシヨン。 2 薬剤を含有せしめた特許請求の範囲第1項記
載の安定なコラーゲン含有化粧用ローシヨン。 3 アルコールを含有せしめた特許請求の範囲第
1項記載の安定なコラーゲン含有化粧用ローシヨ
ン。 4 紫外線吸収剤0.01―2.00重量%を含有せしめ
た特許請求の範囲第1項記載の安定なコラーゲン
含有化粧用ローシヨン。[Claims] 1. A stable collagen-containing cosmetic lotion containing 0.5-2% by weight of any one or more of sodium chloride, potassium chloride or sodium citrate as a solubilization stabilizer, and glucose, sorbitol or An aqueous suspension of 0.3-3% by weight of soluble natural (untreated) collagen having a molecular weight of approximately 300,000 in 75-95% by weight of water containing 3-10% by weight of any one or more of mannitol. A stable collagen-containing cosmetic lotion characterized by containing 5% by weight. 2. A stable collagen-containing cosmetic lotion according to claim 1, which contains a drug. 3. The stable collagen-containing cosmetic lotion according to claim 1, which contains alcohol. 4. A stable collagen-containing cosmetic lotion according to claim 1, which contains 0.01-2.00% by weight of an ultraviolet absorber.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16769481A JPS5869806A (en) | 1981-10-20 | 1981-10-20 | Cosmetic lotion containing stable collagen |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16769481A JPS5869806A (en) | 1981-10-20 | 1981-10-20 | Cosmetic lotion containing stable collagen |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5869806A JPS5869806A (en) | 1983-04-26 |
JPH029561B2 true JPH029561B2 (en) | 1990-03-02 |
Family
ID=15854491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP16769481A Granted JPS5869806A (en) | 1981-10-20 | 1981-10-20 | Cosmetic lotion containing stable collagen |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5869806A (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6089410A (en) * | 1983-10-20 | 1985-05-20 | Shiseido Co Ltd | Cosmetic |
JPS6133105A (en) * | 1984-07-24 | 1986-02-17 | Shiseido Co Ltd | Skin external preparation |
JPS627A (en) * | 1985-03-04 | 1987-01-06 | Shiseido Co Ltd | Skin external agent containing incorporated urea |
JP2769321B2 (en) * | 1988-03-18 | 1998-06-25 | 三省製薬株式会社 | External preparation |
JP2769341B2 (en) * | 1988-12-28 | 1998-06-25 | 三省製薬株式会社 | Stable external base composition |
JP5255777B2 (en) * | 2007-03-26 | 2013-08-07 | 株式会社ファンケル | Collagen triple helical structure stabilizer |
CN104411296A (en) * | 2012-05-16 | 2015-03-11 | 考希德芭以奧帕有限公司 | Cosmetics, pharmaceuticals, and food composition containing pieces or extract from fish eyes |
JP6472635B2 (en) * | 2014-10-14 | 2019-02-20 | 地方独立行政法人東京都立産業技術研究センター | Collagen aqueous solution and method for producing gel using the same |
US20220218585A1 (en) * | 2019-05-27 | 2022-07-14 | Datum Biotech Ltd. | Collagen compositions and uses thereof |
KR102629510B1 (en) * | 2022-04-05 | 2024-01-25 | (주)뉴트리 | Composition comprising collagen with enhanced storage stability and method for preparing the same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54110336A (en) * | 1978-02-16 | 1979-08-29 | Taichirou Akiyama | Skin protecting agent and production thereof |
JPS55149369A (en) * | 1979-05-10 | 1980-11-20 | Ajinomoto Co Inc | Wetting agent composition |
-
1981
- 1981-10-20 JP JP16769481A patent/JPS5869806A/en active Granted
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54110336A (en) * | 1978-02-16 | 1979-08-29 | Taichirou Akiyama | Skin protecting agent and production thereof |
JPS55149369A (en) * | 1979-05-10 | 1980-11-20 | Ajinomoto Co Inc | Wetting agent composition |
Also Published As
Publication number | Publication date |
---|---|
JPS5869806A (en) | 1983-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3157823B2 (en) | Water-containing paste-type pharmaceutical composition | |
JP2681527B2 (en) | Topical for promoting cell activity | |
KR100945971B1 (en) | Acidic composition for external use, and agent for accelerating penetration into the skin or the like of cosmetic preparation, hair-growing agent and preparation for external use each containing the composition | |
JP3199705B2 (en) | Compositions in the form of water-in-oil emulsions having varying shear rates | |
KR930001805B1 (en) | Tretinoin emulsified cream formulations of improved stability | |
JP2000229832A (en) | Skin lotion | |
JPH029561B2 (en) | ||
EP1625844A1 (en) | The composition for external use by percutaneous administration | |
JPH027287B2 (en) | ||
HU190723B (en) | Cosmetical composition containing protein-trace element adducts and process for producing them | |
CN109771326B (en) | Composition for whitening and repairing mask | |
EP0930870B1 (en) | Preparation protecting skin from mechanical irritation | |
EP1752132A2 (en) | Skin cosmetic compositions | |
JPS6239512A (en) | Cosmetic containing carpronium chloride | |
EP0344708B1 (en) | Composition for external application to skin | |
JP5109382B2 (en) | Adapalene-containing external preparation composition | |
JPH09110634A (en) | Skin protecting agent and its production | |
JP2766811B2 (en) | Aqueous skin external preparation | |
JPH1149631A (en) | Hydrous cosmetic | |
JP2002087928A (en) | Humectant for makeup and cosmetic | |
KR20070006626A (en) | Topical composition for transdermal administration | |
KR0141930B1 (en) | Dermatological composition based on an aqueous phase | |
JPH08283138A (en) | Skin cosmetic | |
JPH06145037A (en) | Skin external preparation | |
JP2003171226A (en) | Skin care preparation |